TY  - GEN
AU  - Erice,O
AU  - Labiano,I
AU  - Arbelaiz,A
AU  - Santos-Laso,A
AU  - Munoz-Garrido,P
AU  - Jimenez-Agüero,R
AU  - Olaizola,P
AU  - Caro-Maldonado,A
AU  - Martín-Martín,N
AU  - Carracedo,A
AU  - Lozano,E
AU  - Marin,J J
AU  - O'Rourke,C J
AU  - Andersen,J B
AU  - Llop,J
AU  - Gómez-Vallejo,V
AU  - Padro,D
AU  - Martin,A
AU  - Marzioni,M
AU  - Adorini,L
AU  - Trauner,M
AU  - Bujanda,L
AU  - Perugorria,M J
AU  - Banales,J M
TI  - Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
SN  - 0925-4439
PY  - 2018///1211
KW  - Aged
KW  - Aged, 80 and over
KW  - Animals
KW  - Bile Acids and Salts
KW  - metabolism
KW  - Bile Duct Neoplasms
KW  - drug therapy
KW  - Bile Ducts
KW  - cytology
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - drug effects
KW  - Cell Proliferation
KW  - Chenodeoxycholic Acid
KW  - analogs & derivatives
KW  - Cholangiocarcinoma
KW  - Cholic Acids
KW  - pharmacology
KW  - Cohort Studies
KW  - Disease Progression
KW  - Energy Metabolism
KW  - Epithelial Cells
KW  - Female
KW  - Gastrointestinal Agents
KW  - Humans
KW  - Male
KW  - Mice
KW  - Mice, Nude
KW  - Middle Aged
KW  - Mitochondria
KW  - Receptors, Cytoplasmic and Nuclear
KW  - agonists
KW  - Receptors, G-Protein-Coupled
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.bbadis.2017.08.016
ER  -